Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Chad Moretz, Beth Hahn, John White, Alyssa Goolsby Hunter, Breanna Essoi, Caitlin Elliott & Riju Ray. (2020) Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2715-2725.
Read now
Read now
Kirill A Zykov & Svetlana I Ovcharenko. (2017) Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1125-1133.
Read now
Read now
Bo Ding, Mark Small, Gina Bergström & Ulf Holmgren. (2017) COPD symptom burden: impact on health care resource utilization, and work and activity impairment. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 677-689.
Read now
Read now
Richa Mittal & Sunil K. Chhabra. (2017) GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:1, pages 1-6.
Read now
Read now
Margaret K Pasquale, Yihua Xu, Christine L Baker, Kelly H Zou, John G Teeter, Andrew M Renda, Cralen C Davis, Theodore C Lee & Joel Bobula. (2016) COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 111-121.
Read now
Read now
Zuzana Zbozinkova, Adam Barczyk, Ruzena Tkacova, Arschang Valipour, Neven Tudoric, Kirill Zykov, Attila Somfay, Marc Miravitlles & Vladimir Koblizek. (2016) POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 611-622.
Read now
Read now
Shinji Teramoto, Toshihide Inui & Nobuyuki Hizawa. (2015) A comprehensive assessment using COPD assessment test scoring and modified Medical Research Council dyspnea scoring is necessary for personalized therapy for COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2203-2206.
Read now
Read now
Toshio Suzuki, Yuji Tada, Naoko Kawata, Jun Ikari, Yasunori Kasahara, Yoriko Sakurai, Ken Iesato, Rintaro Nishimura, James West & Koichiro Tatsumi. (2015) Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1199-1205.
Read now
Read now
Jose Luis Lopez-Campos, Alberto Fernandez-Villar, Carmen Calero-Acuña, Cristina Represas-Represas, Cecilia Lopez-Ramírez, Virginia Leiro Fernández, Juan Jose Soler-Cataluña & Ricard Casamor. (2015) Evaluation of the COPD Assessment Test and GOLD patient types: a cross-sectional analysis. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 975-984.
Read now
Read now
Douglas W Mapel, Anand A Dalal, Phaedra T Johnson, Laura K Becker & Alyssa Goolsby Hunter. (2015) Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1477-1486.
Read now
Read now
Nobuyuki Hizawa. (2015) LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1093-1102.
Read now
Read now
Articles from other publishers (2)
Shital Patil & Sham Toshniwal. (2023) Combined pulmonary fibrosis and emphysema: A new horizon of smoker’s lung disease with obstructive and restrictive lung functions!. Global Journal of Health Sciences and Research 0, pages 1-8.
Crossref
Crossref
Maria Montes de Oca1, Maria Victorina Lopez Varela2, Ana Maria B. Menezes3, Fernando C. Wehrmeister3, Larissa Ramirez4 & Marc Miravitlles5. (2021) Respiratory symptoms (COPD Assessment Test and modified Medical Research Council dyspnea scores) and GOLD-ABCD COPD classification: the LASSYC study. Jornal Brasileiro de Pneumologia, pages e20210156.
Crossref
Crossref